← back to search

Daniel H. Mathalon

University of California, San Francisco · US
Area of research
Cognitive Neuroscience · Psychiatry and Mental health
Research interest
Research interests include Schizophrenia research and treatment, Functional Brain Connectivity Studies, Neural dynamics and brain function, and Advanced Neuroimaging Techniques and Applications.
h-index
96
citations
38,327
works
830
NIH funding
primary concept
email

Recent publications

Emergence and Dynamics of Delusions and Hallucinations Across Stages in Early Psychosis
Biological Psychiatry 2025cited by 15position: middledoi
Corollary Discharge Dysfunction to Inner Speech and its Relationship to Auditory Verbal Hallucinations in Patients with Schizophrenia Spectrum Disorders
Schizophrenia Bulletin 2025cited by 5position: middledoi
Prediction of antipsychotic medication inception in antipsychotic-naive youth at clinical high risk for psychosis
Psychological Medicine 2025cited by 5position: middledoi
Excitation/inhibition imbalance and conversion to psychosis in the clinical high risk syndrome: Biophysical modeling finds reduced pyramidal cell excitability across EEG paradigms
medRxiv 2025cited by 1position: lastdoi
Impaired Speaking-Induced Suppression Predicts Degraded Agency and Hallucination Severity in Schizophrenia
Biological Psychiatry Cognitive Neuroscience and Neuroimaging 2025cited by 1position: middledoi
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
Schizophrenia Bulletin 2024cited by 72position: middledoi
P300 in schizophrenia: Then and now
Biological Psychology 2024cited by 33position: middledoi
Bringing Imaging Biomarkers Into Clinical Reality in Psychiatry
JAMA Psychiatry 2024cited by 30position: lastdoi
Using brain structural neuroimaging measures to predict psychosis onset for individuals at clinical high-risk
Molecular Psychiatry 2024cited by 28position: middledoi
Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis
Schizophrenia Bulletin 2024cited by 15position: lastdoi
The Complex Latent Structure of Attenuated Psychotic Symptoms: Hierarchical and Bifactor Models of SIPS Symptoms Replicated in Two Large Samples at Clinical High Risk for Psychosis
Schizophrenia Bulletin 2024cited by 3position: middledoi
Unique functional neuroimaging signatures of genetic versus clinical high risk for psychosis
bioRxiv (Cold Spring Harbor Laboratory) 2024cited by 1position: middledoi
Attention Deficit Hyperactivity Disorder Among Youth at Clinical High Risk of Psychosis
Schizophrenia Bulletin Open 2024cited by 0position: middledoi
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium
Proceedings of the National Academy of Sciences 2023cited by 80position: middledoi
Identifying canonical and replicable multi‐scale intrinsic connectivity networks in 100k+ <scp>resting‐state fMRI</scp> datasets
Human Brain Mapping 2023cited by 69position: middledoi
Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis
JAMA Psychiatry 2023cited by 53position: middledoi
Development of the <scp>PSYCHS</scp> : Positive SYmptoms and Diagnostic Criteria for the <scp>CAARMS</scp> Harmonized with the <scp>SIPS</scp>
Early Intervention in Psychiatry 2023cited by 36position: middledoi
Association of Childhood Area-Level Ethnic Density and Psychosis Risk Among Ethnoracial Minoritized Individuals in the US
JAMA Psychiatry 2023cited by 26position: middledoi
Reliability and clinical utility of spatially constrained estimates of intrinsic functional networks from very short <scp>fMRI</scp> scans
Human Brain Mapping 2023cited by 24position: middledoi
Associations Between Childhood Area-Level Social Fragmentation, Maladaptation to School, and Social Functioning Among Healthy Youth and Those at Clinical High Risk for Psychosis
Schizophrenia Bulletin 2023cited by 20position: middledoi
Spatial Dynamic Subspaces Encode Sex-Specific Schizophrenia Disruptions in Transient Network Overlap and Their Links to Genetic Risk
Biological Psychiatry 2023cited by 19position: middledoi
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses
Molecular Psychiatry 2023cited by 18position: middledoi
Sampling from different populations: Sociodemographic, clinical, and functional differences between samples of first episode psychosis individuals and clinical high-risk individuals who progressed to psychosis
Schizophrenia Research 2023cited by 7position: middledoi
Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk
Molecular Psychiatry 2022cited by 66position: middledoi
Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis
JAMA Psychiatry 2022cited by 62position: lastdoi
Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophrenia
Molecular Psychiatry 2022cited by 47position: lastdoi
Neuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
Translational Psychiatry 2022cited by 37position: middledoi
Moving beyond the ‘CAP’ of the Iceberg: Intrinsic connectivity networks in fMRI are continuously engaging and overlapping
NeuroImage 2022cited by 36position: middledoi
Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort
Schizophrenia Research 2022cited by 17position: lastdoi
Phase Delay of the 40 Hz Auditory Steady-State Response Localizes to Left Auditory Cortex in Schizophrenia
Clinical EEG and Neuroscience 2022cited by 9position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Scott W. Woods · Brigham and Women's Hospital71 papers (2012–2025)Tyrone D. Cannon · Connecticut Mental Health Center67 papers (2012–2025)Diana O. Perkins · Swinburne University of Technology67 papers (2012–2025)Jean Addington · University of Calgary66 papers (2012–2025)Barbara A. Cornblatt · Donald & Barbara Zucker School of Medicine at Hofstra/Northwell66 papers (2012–2025)Kristin S. Cadenhead · UC San Diego Health System65 papers (2012–2025)Carrie E. Bearden · Orygen64 papers (2013–2025)Ming T. Tsuang · University of San Diego61 papers (2012–2024)Thomas H. McGlashan · Yale University57 papers (2012–2022)Larry J. Seidman · Massachusetts Mental Health Center54 papers (2012–2023)Judith M. Ford · University of North Carolina at Chapel Hill46 papers (2012–2025)Brian J. Roach · University of California, San Francisco36 papers (2012–2025)Theo G.M. van Erp · University of Zurich31 papers (2012–2023)Ayşenil Belger · University of North Carolina at Chapel Hill28 papers (2012–2025)Adrian Preda · University of California System24 papers (2012–2023)Sarah McEwen · PAI Life Sciences (United States)23 papers (2013–2022)Jessica A. Turner · Durham University20 papers (2012–2022)Steven G. Potkin · University of California, Irvine18 papers (2012–2023)Ricardo E. Carrión · Northwell Health15 papers (2016–2025)William S. Stone · University of California System14 papers (2016–2025)